Literature DB >> 20860549

Traumatic spinal cord injury alters angiogenic factors and TGF-beta1 that may affect vascular recovery.

Marie-Françoise Ritz1, Ursula Graumann, Bertha Gutierrez, Oliver Hausmann.   

Abstract

Traumatic spinal cord injury (SCI) disrupts the blood-spinal cord barrier and reduces the blood supply caused by microvascular changes. Vessel regression and neovascularization have been observed in the course of secondary injury contributing to microvascular remodeling after trauma. Spatio-temporal distribution of blood vessels and modulation of gene expression of several angiogenic factors have been investigated in rats after spinal cord compression injury. Rarefaction of vessels was detectable at the injury site 2 days after SCI before they disappeared in the developing cavity after 2 and 4 weeks, whereas no changes were observed in the penumbra. Investigation of the temporal expression of angiogenic genes using quantitative RT-PCR disclosed a constant down-regulation of the vascular endothelial growth factor (VEGF), and transient decreases of angiopoietin-1 (Ang-1), platelet-derived growth factor-BB (PDGF-BB), as well as placental growth factor (PlGF), with the lowest values obtained 3 days after injury, when compared to the expression levels obtained in sham-operated rats. Hepatocyte growth factor (HGF) was the only angiogenic factor with a constant increased gene expression when compared with controls, starting at day 3 post-SCI. mRNA levels of transforming growth factor-beta 1 (TGF-β1) were elevated at every time point following SCI, whereas those encoding for the cysteine-rich protein CCN1/CYR61 were upregulated after 2 h, 6 h, and 1 week only. Our data provide an overview of the temporal modulated expression of the major angiogenic factors, hampering revascularization in the lesion during the phase of secondary injury. These findings should be considered in order to improve therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20860549     DOI: 10.2174/156720210793180756

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  13 in total

Review 1.  Targeting microvasculature for neuroprotection after SCI.

Authors:  Janelle M Fassbender; Scott R Whittemore; Theo Hagg
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

2.  Induction of angiopoietin-2 after spinal cord injury.

Authors:  J C Durham-Lee; Y Wu; V U L Mokkapati; A A Paulucci-Holthauzen; O Nesic
Journal:  Neuroscience       Date:  2011-10-04       Impact factor: 3.590

Review 3.  Neurotrauma and mesenchymal stem cells treatment: From experimental studies to clinical trials.

Authors:  Ana Maria Blanco Martinez; Camila de Oliveira Goulart; Bruna Dos Santos Ramalho; Júlia Teixeira Oliveira; Fernanda Martins Almeida
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

Review 4.  Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury.

Authors:  Hemant Kumar; Alexander E Ropper; Soo-Hong Lee; Inbo Han
Journal:  Mol Neurobiol       Date:  2016-05-18       Impact factor: 5.590

5.  Evidence for proangiogenic cellular and humoral systemic response in patients with acute onset of spinal cord injury.

Authors:  Edyta Paczkowska; Dorota Rogińska; Ewa Pius-Sadowska; Alina Jurewicz; Katarzyna Piecyk; Krzysztof Safranow; Violetta Dziedziejko; Ryszard Grzegrzółka; Andrzej Bohatyrewicz; Bogusław Machaliński
Journal:  J Spinal Cord Med       Date:  2014-06-26       Impact factor: 1.985

6.  Inhibition of transforming growth factor-β attenuates brain injury and neurological deficits in a rat model of germinal matrix hemorrhage.

Authors:  Anatol Manaenko; Tim Lekic; Margaret Barnhart; Richard Hartman; John H Zhang
Journal:  Stroke       Date:  2014-01-14       Impact factor: 7.914

Review 7.  Spinal cord injury: a review of current therapy, future treatments, and basic science frontiers.

Authors:  Abhay K Varma; Arabinda Das; Gerald Wallace; John Barry; Alexey A Vertegel; Swapan K Ray; Naren L Banik
Journal:  Neurochem Res       Date:  2013-03-06       Impact factor: 3.996

8.  Vascular disruption and the role of angiogenic proteins after spinal cord injury.

Authors:  Michelle T L Ng; Anthea T Stammers; Brian K Kwon
Journal:  Transl Stroke Res       Date:  2011-10-13       Impact factor: 6.829

9.  Therapeutic Effect of Platelet-Rich Plasma in Rat Spinal Cord Injuries.

Authors:  Nan-Fu Chen; Chun-Sung Sung; Zhi-Hong Wen; Chun-Hong Chen; Chien-Wei Feng; Han-Chun Hung; San-Nan Yang; Kuan-Hao Tsui; Wu-Fu Chen
Journal:  Front Neurosci       Date:  2018-04-23       Impact factor: 4.677

10.  Oral Administration of α-Asarone Promotes Functional Recovery in Rats With Spinal Cord Injury.

Authors:  Min-Jae Jo; Hemant Kumar; Hari P Joshi; Hyemin Choi; Wan-Kyu Ko; J M Kim; Sean S S Hwang; Song Y Park; Seil Sohn; Alvin B Bello; Kyoung-Tae Kim; Soo-Hong Lee; Xiang Zeng; Inbo Han
Journal:  Front Pharmacol       Date:  2018-05-07       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.